Mark Lew - Concepedia

Author

Mark Lew

University of Southern California

Also Known As

Aleksandar Videnovic, Lew, M.F., Lew, Mark F., M F Lew, M LEW, M Lew, M. F. Lew, M. Lew, M.F. Lew, Mark F Lew

145

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

University of Southern California University of South Florida Parkinson's Research and Education Foundation Cleveland Clinic University of Miami

About

Mark Lew is an author at University of Southern California specializing in medicine, neurology, and parkinson disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	1.4K
2	Social Sciences	7	7	402
3	Health Sciences	3	3	324
4	Biochemistry	1	1	23
5	Hepatology	1	1	23

Mark Lew

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia Mitchell F. Brin, Mark Lew, Charles H. Adler, Neurology	1999	444
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–responsive cervical dystonia Allison Brashear, Mark Lew, D.D. Dykstra, Neurology	1999	300
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled study Daniel Truong, Drake D. Duane, Joseph Jankovic, Movement Disorders	2005	240
Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia Mark Lew, Bruce T. Adornato, Drake D. Duane, Neurology Placebo-controlled SafetyPain TherapyPain SyndromeSpinal Cord InjuryIdiopathic Cervical Dystonia	1997	240
Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results Hubert H. Fernandez, David G. Standaert, Robert A. Hauser, Movement Disorders	2014	236
Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease Karl Kieburtz, Barbara C. Tilley, Jordan J. Elm, JAMA	2015	234
Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients Larry E. Tune, Milton E. Strauss, Mark Lew, American Journal of Psychiatry NeuropsychologyPsychotropic MedicationPsychopharmacologyNeuropsychiatryAnticholinergic Drugs	1982	178
Pallidotomy increases activity of motor association cortex in parkinson's disease: A positron emission tomographic study Scott T. Grafton, Cheryl Waters, James P. Sutton, Annals of Neurology	1995	165
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia Daniel Truong, Matthew Brodsky, Mark Lew, Parkinsonism & Related Disorders Cervical DystoniaGynecologyLong-term Efficacy	2010	150
Influence of Heterozygosity for Parkin Mutation on Onset Age in Familial Parkinson Disease Mei Sun, Jeanne C. Latourelle, G. Frederick Wooten, Archives of Neurology	2006	143

Page 1